Lumen Bulls Lean In Ahead of Q3 Print

Lumen Technologies heads into its November 3 earnings report with options traders distinctly more bullish than usual, even as short sellers maintain a meaningful presence in the stock.

The clearest signal is in the options market. The put/call ratio has dropped to 0.68, roughly 1.4 standard deviations below its 20-day average of 0.75, making it one of the more call-heavy readings of the past year. That points to heavier demand for upside exposure than defensive hedging ahead of the print. The stock has recovered 6.8% over the past week to $4.88, though it remains 11.9% lower on the month, leaving it well off levels from earlier in October. The lending market adds little urgency to the short thesis. Availability is extremely loose at around 1,457%, meaning there are more than 14 shares available to borrow for every one already lent out. Cost to borrow has also fallen sharply, dropping 35% over the past week to just 0.29%, a multi-month low.

Short interest is real but not extreme. At 6.7% of the free float, roughly 68.7 million shares are held short, a level that has been broadly stable over the past month, down about 2.7% in 30 days despite edging up 4.3% in the past week. The ORTEX short score of 47.5 sits in the lower half of its range, and the stock's short score factor rank places it in the 24th percentile. That points to a position that is present but not escalating, short sellers are not piling in ahead of the print.

The bull and bear debate on Lumen centres on whether its transformation can outrun its debt burden. Bulls point to the pivot toward enterprise and digital services, which now account for the bulk of revenue, and argue the Alkira acquisition strengthens Lumen's networking capabilities at a time when demand for advanced enterprise connectivity is growing. Bears counter that revenue continues to decline, the balance sheet carries heavy debt, and execution of the turnaround remains uncertain. The analyst consensus is a hold, with a mean price target of $7.49 against the current price of $4.88, though that consensus reflects positioning as of early October and no recent target changes have been recorded. The EV/EBITDA multiple of around 7x has drifted slightly lower over the past month, reflecting the stock's weaker price action rather than any material change in the earnings picture.

One ownership detail stands out. The CEO, Kathleen Johnson, made an open-market purchase of 100,000 shares at $6.13 in August, a discretionary buy not made under a 10b5-1 plan. That purchase now sits at a loss relative to the current $4.88 price, but it was the only open-market purchase among recent insider activity and carries more signal than the compensation-related grants that dominate the rest of the insider register. BlackRock has also grown its stake to 13.8% of shares as of September 30, adding nearly 10 million shares in the most recent reported period. Wikipedia page views for Lumen are running at a z-score of 3.2 against the prior 90 days, a notable spike in retail attention in the two weeks before earnings.

The November 3 print will test whether Lumen's enterprise revenue trajectory is stable enough, and its EBITDA profile durable enough, to justify a stock that options traders are treating as a recovery candidate while the broader analyst community remains firmly on the sidelines.